Literature DB >> 9274462

Treatment of autoimmune hepatitis.

P J Johnson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9274462      PMCID： PMC1027218          DOI： 10.1136/gut.41.1.3

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  19 in total

1.  ACTIVE 'JUVENILE' CIRRHOSIS CONSIDERED AS PART OF A SYSTEMIC DISEASE AND THE EFFECT OF CORTICOSTEROID THERAPY.

Authors:  A E READ; S SHERLOCK; C V HARRISON
Journal:  Gut       Date:  1963-12       Impact factor: 23.059

2.  Maintenance of remission in autoimmune chronic active hepatitis with azathioprine after corticosteroid withdrawal.

Authors:  A J Stellon; J J Keating; P J Johnson; I G McFarlane; R Williams
Journal:  Hepatology       Date:  1988 Jul-Aug       Impact factor: 17.425

3.  Controlled trial of prednisone and azathioprine in active chronic hepatitis.

Authors:  I M Murray-Lyon; R B Stern; R Williams
Journal:  Lancet       Date:  1973-04-07       Impact factor: 79.321

4.  Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis.

Authors:  R D Soloway; W H Summerskill; A H Baggenstoss; M G Geall; G L Gitnićk; I R Elveback; L J Schoenfield
Journal:  Gastroenterology       Date:  1972-11       Impact factor: 22.682

5.  The treatment of active chronic hepatitis with 6-mercaptopurine and azathioprine.

Authors:  S P Mistilis; C R Blackburn
Journal:  Australas Ann Med       Date:  1967-11

6.  Hepatitis C virus antibodies among risk groups in Spain.

Authors:  J I Esteban; R Esteban; L Viladomiu; J C López-Talavera; A González; J M Hernández; M Roget; V Vargas; J Genescà; M Buti
Journal:  Lancet       Date:  1989-08-05       Impact factor: 79.321

7.  Sustained remission after corticosteroid therapy of severe hepatitis B surface antigen-negative chronic active hepatitis.

Authors:  A J Czaja; S J Beaver; M T Shiels
Journal:  Gastroenterology       Date:  1987-01       Impact factor: 22.682

8.  Relapse following treatment withdrawal in patients with autoimmune chronic active hepatitis.

Authors:  J E Hegarty; K T Nouri Aria; B Portmann; A L Eddleston; R Williams
Journal:  Hepatology       Date:  1983 Sep-Oct       Impact factor: 17.425

9.  Influence of aetiology, clinical and histological features on survival in chronic active hepatitis: an analysis of 204 patients.

Authors:  J J Keating; C J O'Brien; A J Stellon; B C Portmann; R D Johnson; P J Johnson; R Williams
Journal:  Q J Med       Date:  1987-01

10.  Randomised controlled trial of azathioprine withdrawal in autoimmune chronic active hepatitis.

Authors:  A J Stellon; J E Hegarty; B Portmann; R Williams
Journal:  Lancet       Date:  1985-03-23       Impact factor: 79.321
View more
  4 in total

1.  Indications for referral and assessment in adult liver transplantation: a clinical guideline. British Society of Gastroenterology.

Authors:  J Devlin; J O'Grady
Journal:  Gut       Date:  1999-12       Impact factor: 23.059

2.  Relationship between autoimmune hepatitis and HLA-DR4 and DRbeta allelic sequences in the third hypervariable region in Chinese.

Authors:  X Ma; D K Qiu
Journal:  World J Gastroenterol       Date:  2001-10       Impact factor: 5.742

Review 3.  Autoimmune hepatitis.

Authors:  Diego Vergani; Maria Serena Longhi; Dimitrios P Bogdanos; Yun Ma; Giorgina Mieli-Vergani
Journal:  Semin Immunopathol       Date:  2009-06-17       Impact factor: 9.623

Review 4.  Management of autoimmune hepatitis: Focus on pharmacologic treatments beyond corticosteroids.

Authors:  Marta Casal Moura; Rodrigo Liberal; Hélder Cardoso; Ana Maria Horta E Vale; Guilherme Macedo
Journal:  World J Hepatol       Date:  2014-06-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.